Clinical impact of multidrug-resistant organisms in liver cirrhosis: A retrospective cohort study in the intensive care setting

doi:10.3748/wjg.v31.i39.111261

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 39

This Article

(67)

(61)

(0)

(12)

(1214)

(5)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Oct 21, 2025; 31(39): 111261
Published online Oct 21, 2025. doi: 10.3748/wjg.v31.i39.111261

Full Size Figure Download Figure

Figure 3 Kaplan-Meier curves for 28-day transplant-free survival in intensive care unit patients with cirrhosis, stratified by multidrug-resistant organism status and clinical phenotype. A: 28-day survival of acute-on-chronic liver failure patients without and multidrug-resistant organism (MDRO) infection (P = 0.257); B: 28-day survival of acute decompensation patients without and with MDRO infection (P = 0.225); C: 28-day survival of acute-on-chronic liver failure patients without and with MDRO colonization at intensive care unit admission (P = 0.956); D: 28-day survival of acute decompensation patients without and with MDRO colonization at intensive care unit admission (P = 0.542).

Citation: Kosuta I, Babel J, Domislovic V, Susak F, Peretin L, Varda Brkic D, Marekovic I, Radonic R, Mrzljak A. Clinical impact of multidrug-resistant organisms in liver cirrhosis: A retrospective cohort study in the intensive care setting. World J Gastroenterol 2025; 31(39): 111261
URL: https://www.wjgnet.com/1007-9327/full/v31/i39/111261.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i39.111261

Kosuta I, Babel J, Domislovic V, Susak F, Peretin L, Varda Brkic D, Marekovic I, Radonic R, Mrzljak A. Clinical impact of multidrug-resistant organisms in liver cirrhosis: A retrospective cohort study in the intensive care setting. World J Gastroenterol 2025; 31(39): 111261 [PMID: 41180792 DOI: 10.3748/wjg.v31.i39.111261]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.